102 results
Page 4 of 6
F-1
EX-5.1
drk s7w92gn
3 Jun 19
Registration statement (foreign)
4:33pm
F-1
EX-1.1
rqx 243dvr
3 Jun 19
Registration statement (foreign)
4:33pm
F-1
EX-10.1
pz1dd5zadl9 tgnjt
3 Jun 19
Registration statement (foreign)
4:33pm
6-K
EX-99.1
wed5yoho1zmre
3 Jun 19
Current report (foreign)
7:00am
6-K
EX-99.3
1ijel
3 Jun 19
Current report (foreign)
7:00am
6-K
EX-99.1
skt3mqmeyh
28 May 19
Current report (foreign)
7:23am
DRS
0i7yn2e ban0byigxo7
3 May 19
Draft registration statement
12:00am
20-F/A
EX-4.12
8dvn0h
26 Apr 19
Annual report (foreign) (amended)
4:54pm
S-8
EX-5.1
dkiqx ptfcx
22 Mar 19
Registration of securities for employees
8:33am
20-F
EX-4.12
3wujf x2002
22 Mar 19
Annual report (foreign)
8:02am
20-F
EX-2.1
rhd0 2gvx7
22 Mar 19
Annual report (foreign)
8:02am
20-F
EX-1.1
pcpnfv
22 Mar 19
Annual report (foreign)
8:02am
20-F
19bzk
22 Mar 19
Annual report (foreign)
8:02am
6-K
EX-99.1
4w4hs6 hlh
21 Mar 19
Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights
7:04am
6-K
EX-99.1
ebug92i2oyxd2 kh
19 Mar 19
Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer
9:39am
6-K
EX-99.1
o2kkpkikay
7 Dec 18
Orchard Therapeutics Appoints Industry Veteran Alicia Secor to its Board of Directors
7:45am
424B4
ogrpaq qta90
31 Oct 18
Prospectus supplement with pricing info
4:36pm
S-8
EX-5.1
fb6cit8vsv48
30 Oct 18
Registration of securities for employees
9:48pm
F-1/A
EX-5.1
53gvh4cqiaegp03h9jc
26 Oct 18
Registration statement (foreign) (amended)
10:08am
F-1/A
EX-10.4
6ki2969srqo
23 Oct 18
Registration statement (foreign) (amended)
6:15am